Reviewed for legal accuracy by Gary Matthews, Solicitor · Last reviewed: June 2026

What is a cancer stage shift?

A cancer stage shift is the advance of a tumour from a lower stage to a higher one during the period a diagnosis was negligently delayed. It is also called stage migration or upstaging.

Cancer is described by a stage, a measure of how far it has spread when it is found.

A stage shift is the difference between two points in time. The first is the stage the cancer would have been at if a competent doctor had diagnosed it when the symptoms or test results should have prompted action. The second is the more advanced stage it had actually reached by the time it was finally diagnosed. That difference is the heart of a delayed cancer diagnosis claim. Irish law compensates the harm a negligent delay causes, and the stage shift is how that harm is measured.

This page is the reference the rest of our cancer misdiagnosis work points to when it describes how delay turns into legal damage. It explains the mechanism. Whether a delay was negligent in the first place is covered on our delayed cancer diagnosis page. What a proven shift is worth is covered on the compensation page linked above.

Negligence stage shift is not the same as statistical stage migration

One distinction is worth drawing clearly, because it trips up even careful writers. Doctors and statisticians sometimes use the phrase "stage migration" to describe an effect of better scanning technology. Sharper imaging finds spread that older scans would have missed, and reclassifies patients into higher stages. Survival within each stage then appears to improve even though no patient is actually better off.

That statistical artefact, known as the Will Rogers phenomenon, is not what this page is about. A negligence stage shift means a real tumour that genuinely advanced because nobody acted in time. The first is a quirk of measurement, the second is compensable harm.

What is TNM staging?

TNM staging is the international system that describes a cancer by three features. T stands for the size or extent of the primary tumour, N for spread to nearby lymph nodes, and M for spread to distant parts of the body.

The system is maintained by the American Joint Committee on Cancer and the Union for International Cancer Control, and the current eighth edition has been in use worldwide since 2018.^[1] A doctor combines the three letters into an overall stage, usually written as stages 1 to 4. Stage 1 is small and localised, and stage 4 has spread to distant organs. The same system underpins the Irish cancer pathway. It is the language an expert and an Irish court use when comparing where a cancer was against where it should have been found.

What stages 1 to 4 mean

The T, N, and M letters combine into an overall stage from 1 to 4, and the number is the part most people recognise. In plain terms, a lower number means the cancer is smaller and more contained, and a higher number means it has spread further. The table below sets out what each stage usually means and why a shift to a higher stage matters in a claim.

These are general descriptions. The precise meaning of each stage differs by cancer type, and not every cancer is staged this way. Some, such as leukaemia and most brain tumours, use different systems.

Stage is not the same as grade

Stage and grade are different things, and the difference matters when an expert assesses a delay. Stage describes how far a cancer has spread, which is what a stage shift changes. Grade describes how abnormal the cancer cells look under a microscope, which signals how quickly the cancer is likely to grow. A delay does not change a cancer's grade, but a faster-growing, higher-grade cancer can shift stage more quickly during the same delay. A precise claim keeps the two separate, because a stage shift is a change in spread, not a change in the cancer's underlying biology.

Does the stage change after diagnosis?

No. The stage recorded at diagnosis is fixed and does not change later. If a stage 2 cancer comes back or spreads after treatment, it is still described as stage 2 that has recurred or progressed. It does not become a new stage 3 or 4. This matters in a claim. A stage shift here means the difference between two diagnostic points: the stage a timely diagnosis would have recorded, and the stage actually recorded later. It is not about how the cancer behaves after it is finally found.

Clinical staging and pathological staging are not the same

There are two ways a cancer is staged, and the difference matters in a claim. Clinical staging, written as cTNM, is based on examination and imaging before treatment. Pathological staging, written as pTNM, is based on examining tissue removed at surgery.^[2]

An expert reconstructing where a cancer was at the date of the missed diagnosis usually works from the clinical evidence that existed then, such as scans and reports. Tissue is often only removed much later, at the actual diagnosis, so pathological staging from that point describes the cancer after it advanced, not before. The reconstruction therefore leans on the clinical record from the missed date. A complete set of contemporaneous scans and reports can decide whether a stage shift is provable at all.

How does a delayed diagnosis cause a stage shift?

A delay causes a stage shift when a tumour keeps growing or spreading during the months it goes undiagnosed, moving it from a lower stage to a higher one. The longer the delay, the higher the chance of a shift, though the size of the risk depends heavily on the type of cancer.

A cancer does not pause while a referral sits unactioned or a scan goes unread. A tumour that was small and confined when symptoms first appeared can grow, reach lymph nodes, or seed distant organs. All of this can happen in the time it takes for the diagnosis to catch up. How quickly that happens varies enormously between cancers, which is why some delays cause profound harm while others, on the evidence, change very little.

Irish data shows how much the cancer type matters. A study using National Cancer Registry Ireland data modelled the probability of an upward stage shift after a delay in starting treatment.^[3] The numbers below show how the same delay carries a very different risk depending on the cancer. Breast cancer advances relatively slowly, while non-small-cell lung cancer advances fast, so a delay of the same length is far more likely to cause a shift in lung cancer.

These are modelled probabilities from population data, not outcomes for any individual. They show the pattern that longer delays raise the chance of a shift, and that the size of that chance depends heavily on the cancer. Each claim turns on its own clinical facts and expert evidence.

A worked example of a stage shift

It helps to see a shift in the language doctors actually use. The following is a simple illustration of the mechanism, not a real or typical case. Suppose a breast tumour is small and confined when a woman first reports a lump, with no sign of spread. In TNM terms that might be recorded as T1 N0 M0, an overall stage 1.

If a competent assessment is missed and the diagnosis comes months later, the same cancer might by then measure larger and have reached a nearby lymph node, recorded as T2 N1 M0, an overall stage 2. The move from stage 1 to stage 2 is the stage shift.

Its legal significance is not the label itself but what the label represents, such as the loss of a simpler treatment, a worse outlook, or a shorter life. An oncologist would have to prove, from the records, that the earlier, lower stage was the true position when the diagnosis should have been made.

Why does a stage shift matter legally in Ireland?

A stage shift matters legally because it is the measurable harm that turns a negligent delay into a compensable injury. Irish law does not compensate the delay itself, it compensates the damage the delay caused, and the stage shift is how that damage is shown. This is the thread that connects a missed diagnosis to your ability to understand and pursue compensation for injury in Ireland.

An Irish clinical negligence claim has two parts that both have to be proven. The first is breach of duty, judged by the Dunne principles from Dunne v National Maternity Hospital [1989] IR 91, which ask whether the doctor was guilty of a failure that no reasonably competent practitioner of equal standing would have made when acting with ordinary care.

The Supreme Court reaffirmed that test for cancer cases in Morrissey v HSE [2020] IESC 6, and also confirmed that the HSE owes patients a non-delegable duty, so it stays primarily liable even where screening is outsourced to a laboratory.^[4] National cancer guidelines inform that standard but do not replace it.

The High Court confirmed in Perez v Coombe [2025] IEHC 396 that guidelines guide the assessment of breach without binding the court.^[6]

The second part is causation, and this is where a stage shift does its work. Proving the delay was negligent is not enough. You also have to prove the delay caused harm. That usually means proving the cancer would have been at an earlier, more treatable stage if it had been found on time. That earlier-stage finding is what connects the breach to a real loss, whether that loss is a worse prognosis, harsher treatment, or a shortened life.

The way the law treats a lost prospect of a better outcome is the loss of chance doctrine. It is explained on our loss of chance in cancer claims page, and in its general form on the loss of chance doctrine page.

Does a higher stage mean more compensation?

No. A higher stage at diagnosis does not automatically mean a larger award. Compensation depends on proving that the negligent delay caused the shift, and then on the actual impact of that shift on the person's treatment, prognosis, and life.

It is a common and understandable assumption that a later stage simply equals more money. Irish law does not work that way. If a cancer was always going to be found late because of how aggressively it behaves, a late stage is not the fault of any delay. It founds no claim. The compensable harm is only the part of the advance that a timely diagnosis would have prevented.

Where that is established, the value comes from the consequences. These include the difference between curative and palliative treatment, the extra surgery or chemotherapy endured, and any reduction in life expectancy. Those consequences are assessed under the Personal Injuries Guidelines for general damages, with separate uncapped special damages for financial losses. We set out how that assessment works on the page covering how cancer claims are valued.

How is a stage shift proven in a claim?

A stage shift is proven by independent expert oncology evidence. The expert reconstructs the stage the cancer was at on the date of the missed diagnosis, using the scans, blood results, and records that existed at the time. That is then compared to the stage at actual diagnosis.

This is a forensic exercise, not an assumption. An oncologist works backward from the cancer as it was eventually found. The contemporaneous clinical evidence is used to establish, on the balance of probabilities, where it stood at the earlier date. The quality of that evidence decides the case. Vague expert language about a "possible" earlier stage rarely survives scrutiny, while a precise reconstruction of the tumour, nodes, and any spread carries real weight. Our page on the expert medical report explains how these reports are commissioned and used.

The Irish courts have shown how demanding this proof can be. A real delay and a real advance in the cancer do not, on their own, win a claim. The shift still has to be tied to the delay rather than to the cancer's own behaviour.

In Crumlish v HSE [2024] IECA 244, a breast cancer claim alleging a five-month delay failed at what the Court of Appeal called the first causation hurdle. The plaintiff could not prove the lump examined at the earlier visit was the cancer rather than a benign cyst.^[5] The court warned against relying on generalised tumour growth rates in place of patient-specific evidence.

The defence in delay cases often runs a two-way argument on tumour growth. Too slow, and the delay changed little. Too fast, and the cancer was not detectable at the earlier date. We explain that argument and how it is met on our causation in medical negligence page. The lesson from Crumlish is that a stage shift must be proven with rigour, which is why the records that fix the cancer's stage at each point are gathered early.

How does a stage shift map to the heads of damage?

Once a stage shift is proven, it feeds into two heads of damage. General damages cover the pain, suffering, and reduced life expectancy it causes. Uncapped special damages cover the financial losses that follow, such as extra care and lost earnings.

General damages compensate the human cost. The Personal Injuries Guidelines set the framework for these. The first category in the Guidelines deals specifically with injuries resulting in a foreshortened life expectancy, which is often exactly what a negligent stage shift produces.^[8]

Special damages compensate quantifiable losses and are not capped, covering past and future costs such as additional treatment, care, home adaptations, and lost income. In cancer claims the special damages are usually the larger part, because the lifelong consequences of a more advanced cancer carry real financial weight. Where a delay shortens life, our reduced life expectancy page explains how that specific loss is approached, and the heads of damage are set out in full there.

Timing also has a legal edge. The clock for a claim runs for two years less one day from your date of knowledge, the date you first knew, or ought reasonably to have known, that a significant injury was connected to your care.^[7] Waiting for an internal hospital review or an open-disclosure meeting does not pause that clock. Our date of knowledge page explains how the deadline is worked out in cancer cases.

How we help with this part of a claim

We work with independent oncology experts to reconstruct the stage your cancer was at when it should have been diagnosed. Setting that against the stage actually reached shows the harm the delay caused.

In practice that means gathering the contemporaneous records early and instructing the right specialists to establish the breach-date stage. The staging evidence has to be precise enough to carry both the causation argument and the assessment of damages. Because medical negligence claims in Ireland are exempt from the Injuries Resolution Board under section 3(d) of the PIAB Act 2003, these cases proceed directly to the High Court, where they are managed in the dedicated Clinical Negligence List. Strong, specific staging evidence is what gives a personal injury claim of this kind its foundation.

Common questions